Trial intelligence / Profile preview

ESPB vs IV Morphine for Postoperative Analgesia in Spine Surgery

NCT05350696Unknown

Sponsor
Sohag University
Start
Nov 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoint: Postoperative analgesia at 24 hours. Status: unknown.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05350696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05350696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call